Genetic Factors Affecting ALA (Alpha-Linolenic Acid) Levels

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on the genes behind fatty-acid metabolism and nutrition. Browse all Diet & Genetics education

ALA — alpha-linolenic acid — is the essential plant-based omega-3 fatty acid found in flaxseed, chia, walnuts, and canola oil. Your body cannot make it, so you get it from food. But what happens to ALA once it is inside you depends heavily on your genes, particularly the enzymes that convert it into the longer-chain omega-3s EPA and DHA.

This article covers the named genes that most affect ALA metabolism and blood levels, why conversion efficiency varies so widely between people, and what a pathway-level genetic test can reveal. (Note: ALA here means alpha-linolenic acid, not alpha-lipoic acid, a different antioxidant compound.)

What ALA is and why it matters

Alpha-linolenic acid is one of two essential fatty acids humans must obtain from diet. It serves as the raw material for EPA and DHA, the omega-3s most associated with cardiovascular and neurological biology. Only a fraction of dietary ALA is converted to EPA and DHA, and that fraction is strongly shaped by genetics, sex, and background diet.

The FADS1 and FADS2 gene cluster

The most influential genes for ALA metabolism sit in the FADS cluster on chromosome 11. FADS1 and FADS2 encode the delta-5 and delta-6 desaturase enzymes that perform the key conversion steps from ALA toward EPA and DHA.

A widely studied variant, rs174537 near FADS1, is associated with substantial differences in desaturase activity. Carriers of one version convert ALA to long-chain omega-3s more efficiently, while carriers of the other tend to have lower EPA and DHA levels from the same dietary intake. FADS2 variants such as rs174575 modify the same pathway. Population studies show these alleles vary widely across ancestral groups, a signature of dietary adaptation over human history.

ELOVL2 and the elongation step

Conversion is not only about desaturation. ELOVL2 encodes an elongase enzyme that adds carbon length on the path to DHA. Variants in ELOVL2 have been associated with circulating DHA levels and are among the genes that fine-tune how much benefit a person derives from plant-based omega-3s. Together, FADS and ELOVL variants explain a meaningful share of person-to-person differences in omega-3 status.

What the research shows

Research consistently finds that ALA is an inefficient precursor for most people, with conversion to DHA often in the low single-digit percentages — and that FADS genotype is one of the largest genetic contributors to that variability. This has practical relevance for people who rely on plant sources of omega-3, such as those following vegetarian or vegan diets, where lower desaturase activity can mean lower long-chain omega-3 status despite adequate ALA intake.

Diet, ALA, and your genetics

Understanding your conversion genetics can inform, but does not dictate, dietary choices. People who convert ALA poorly may derive more benefit from preformed EPA and DHA sources, while efficient converters may do well on plant-based ALA. These are general nutritional considerations — specific supplement or diet decisions belong with a qualified healthcare provider or registered dietitian who can factor in your full health picture.

What your genetic results reveal

A pathway-level genetic test can show which FADS and ELOVL variants you carry and place them within your broader nutrient-metabolism biology. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, framing fatty-acid genes as part of a connected profile rather than a single number.

It will not diagnose a deficiency or measure your blood omega-3 level — that requires laboratory testing. Genetics is a guide, not a guarantee: the test tells you about your biology, not what to eat. That context, paired with professional guidance, turns generic omega-3 advice into something personal.

Frequently Asked Questions

What does ALA stand for in nutrition?

ALA usually means alpha-linolenic acid, the essential plant-based omega-3 fatty acid found in flaxseed, chia, and walnuts. It is the precursor your body converts into EPA and DHA. Note that ALA can also abbreviate alpha-lipoic acid, a separate antioxidant compound with different biology and different governing genes.

Which genes affect ALA conversion the most?

The FADS1 and FADS2 genes on chromosome 11 have the largest effect. They encode the desaturase enzymes that convert ALA toward EPA and DHA, and variants like rs174537 strongly influence conversion efficiency. ELOVL2 affects the elongation step toward DHA, adding further person-to-person variability in omega-3 status.

Why do some people get less benefit from plant omega-3s?

Conversion of ALA to EPA and DHA is inefficient for most people, and FADS genotype is a major reason it varies. Carriers of lower-activity desaturase variants convert less ALA into long-chain omega-3s, so they may reach lower EPA and DHA levels even with adequate flaxseed or chia intake.

Does a genetic test measure my omega-3 levels?

No. A genetic test shows which conversion variants you carry, such as those in FADS1 and ELOVL2, but it does not measure the omega-3 fatty acids in your blood. Measuring actual levels requires laboratory testing. Genotype provides context; a blood panel and a clinician provide the measurement and interpretation.

Want to know whether you are an efficient omega-3 converter? Take the Precision Peptide Genetic Test to see FADS and ELOVL variants mapped across your 14 biological pathways — the "test before you invest" approach to precision nutrition.

This article is part of the PlexusDx Education Hub. Browse all Diet & Genetics education

Peptide testing disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.